» Articles » PMID: 7819036

DNA Ploidy and S-phase Fraction As Prognostic Factors in Patients with Uveal Melanomas

Overview
Journal Br J Cancer
Specialty Oncology
Date 1995 Jan 1
PMID 7819036
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

In 96 patients with uveal malignant melanomas the tumours were investigated by DNA flow cytometry. Thirty-eight per cent of the melanomas were aneuploid. By univariate analysis significant correlations with survival were found for histological type, tumour size, DNA ploidy, evidence of 'blind eye' and S-phase fraction. By multivariate analysis, significant prognostic variables were found to be histological type (P = 0.0008), tumour size (P < 0.0001) and DNA ploidy (P = 0.0038). Evidence of 'blind eye' was not significantly correlated with survival after adjustments for the other variables mentioned above. The S-phase fraction could be estimated in all 60 diploid tumours and in 12 of 36 aneuploid melanomas. By univariate analysis this variable was found to be a significant prognostic factor, but did not remain so after adjustment for ploidy, histological type and tumor size. We further conclude that patients with small DNA diploid uveal melanomas of spindle cell type have a rather favourable prognosis.

Citing Articles

The genetics of uveal melanoma: an emerging framework for targeted therapy.

Harbour J Pigment Cell Melanoma Res. 2012; 25(2):171-81.

PMID: 22268848 PMC: 4470256. DOI: 10.1111/j.1755-148X.2012.00979.x.


A comparative transcriptomic analysis of uveal melanoma and normal uveal melanocyte.

An J, Wan H, Zhou X, Hu D, Wang L, Hao L PLoS One. 2011; 6(1):e16516.

PMID: 21305041 PMC: 3030591. DOI: 10.1371/journal.pone.0016516.


Effects of proton beam irradiation on uveal melanomas: a comparative study of Ki-67 expression in irradiated versus non-irradiated melanomas.

Chiquet C, Grange J, Ayzac L, Chauvel P, Patricot L, Devouassoux-Shisheboran M Br J Ophthalmol. 1999; 84(1):98-102.

PMID: 10611107 PMC: 1723230. DOI: 10.1136/bjo.84.1.98.

References
1.
Karlsson M, BOERYD B, Carstensen J, Kagedal B, Bratel A, Wingren S . DNA ploidy and S-phase in primary malignant melanoma as prognostic factors for stage III disease. Br J Cancer. 1993; 67(1):134-8. PMC: 1968202. DOI: 10.1038/bjc.1993.23. View

2.
Seregard S, Kock E . Conjunctival malignant melanoma in Sweden 1969-91. Acta Ophthalmol (Copenh). 1992; 70(3):289-96. DOI: 10.1111/j.1755-3768.1992.tb08566.x. View

3.
Schwartz G, Schwarting R, Rabindranauth P, FINKEL G . Clinical applications of serum and tissue markers in malignant disease: breast cancer as the paradigm. Clin Chem. 1993; 39(11 Pt 2):2404-12. View

4.
Karlsson M, BOERYD B, Carstensen J, Kagedal B, Wingren S . DNA ploidy and S-phase fraction in primary melanomas and their regional metastases. Melanoma Res. 1994; 4(1):47-51. DOI: 10.1097/00008390-199402000-00007. View

5.
Baisch H, Gohde W, LINDEN W . Analysis of PCP-data to determine the fraction of cells in the various phases of cell cycle. Radiat Environ Biophys. 1975; 12(1):31-9. DOI: 10.1007/BF02339807. View